Laxative Enteric Coated (Bisacodyl 5mg)
Brand Names: Laxative Enteric Coated
Methodology & AI Transparency ⓘ
Laxative Enteric Coated (Bisacodyl 5mg) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Marketed under the trade name Laxative Enteric Coated (registered by Marc Glassman, Inc., RxNorm 308753-B68998404), this over-the-counter branded formulation contains Bisacodyl 5mg within the Stimulant Laxative therapeutic class.
- 2 Real-world patient consensus: Branded stimulant laxative presentation of Bisacodyl 5mg (Marc Glassman, Inc.); generic reference: /meds/bisacodyl-5mg.
- 3 Typical cash cost range: Dispensing cost comparison spans $34.32 mail/discount cash up to $90.95 uninsured retail (federal NADAC $0.3586).
- 4 Top reported side effects / signs: Leading openFDA/SPL adverse events for Laxative Enteric Coated (Bisacodyl 5mg): constipation (8%), nausea (7.5%), headache (7.7%).
Ask our AI Specialists anything about Laxative Enteric Coated (Bisacodyl 5mg)
Laxative Enteric Coated (Bisacodyl 5mg) Mechanism, CYP450 Pathways & DailyMed Monograph
Marketed under the trade name Laxative Enteric Coated (registered by Marc Glassman, Inc., RxNorm 308753-B68998404), this over-the-counter branded formulation contains Bisacodyl 5mg within the Stimulant Laxative therapeutic class. Per 2019-09-18 DailyMed labeling (68998-404, 69168-404), clinical use centers on 5 mg/1 Tablet, Sugar Coated; 5 mg/1 Tablet, Coated: Uses for temporary relief of occasional constipation and irregularity this product generally produces bowel movement in 6.
At the receptor and enzymatic level, Laxative Enteric Coated delivers Bisacodyl 5mg to execute stimulant laxative modulation with class-characteristic hepatorenal disposition. Specific to the Laxative Enteric Coated commercial product (NDC 68998-404, 69168-404, RxCUI 308753-B68998404), tablet/vehicle compounding registered by Marc Glassman, Inc. standardizes delivery across 5 mg/1 Tablet, Sugar Coated; 5 mg/1 Tablet, Coated, contrasting $34.32 discount cash access against $90.95 walk-in retail pricing.
Systemic exposure to Laxative Enteric Coated (Bisacodyl 5mg) reflects Approximately 76% to 88% enteral uptake across labeled Laxative Enteric Coated (Bisacodyl 5mg) strengths absorption kinetics and predominantly hepatic biotransformation with renal elimination of polar laxative enteric coated (bisacodyl 5mg) conjugates, sustaining receptor engagement across a Steady-state plasma equilibrium reached over 3–12 hour t½ intervals for Laxative Enteric Coated (Bisacodyl 5mg) half-life window (maximum serum exposure occurs 2–5 hours after laxative enteric coated (bisacodyl 5mg) dosing response profile).
Dosing protocols (5 mg/1 Tablet, Sugar Coated or 5 mg/1 Tablet, Coated) balance efficacy (77.00% patient satisfaction across 20 logs) against constipation (8% of reports), headache (7.7% of reports), nausea (7.5% of reports), with strict avoidance in confirmed ige-mediated allergy or cutaneous reaction to laxative enteric coated (bisacodyl 5mg) (bisacodyl 5mg) components; uncompensated hepatic or renal insufficiency incompatible with laxative enteric coated (bisacodyl 5mg) (5 mg/1 tablet, sugar coated) clearance.
Reconcile eGFR-adjusted medications before escalating Laxative Enteric Coated (Bisacodyl 5mg) in polypharmacy regimens.
Shifts in intragastric pH can modestly influence dissolution kinetics of oral Laxative Enteric Coated (Bisacodyl 5mg) dosage forms.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Confirmed IgE-mediated allergy or cutaneous reaction to Laxative Enteric Coated (Bisacodyl 5mg) (Bisacodyl 5mg) components
- Uncompensated hepatic or renal insufficiency incompatible with Laxative Enteric Coated (Bisacodyl 5mg) (5 mg/1 Tablet, Sugar Coated) clearance
Logged Side-Effect Incidence (20 Reports)
Laxative Enteric Coated (Bisacodyl 5mg) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Laxative Enteric Coated (Bisacodyl 5mg))
Human clinical trial evidence for Laxative Enteric Coated (Bisacodyl 5mg) is indexed directly from the U.S. National Library of Medicine NCBI PubMed database. Explore recent randomized trials in the PubMed Research Pulse .
Laxative Enteric Coated (Bisacodyl 5mg) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $0.3586/unit (~$10.76/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $90.95 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 20 Anonymous DotMD Community Micro-Logs | $34.32 / mo | View logs ↓ |
Laxative Enteric Coated (Bisacodyl 5mg) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Laxative Enteric Coated (Bisacodyl 5mg) RxNorm Concept ID | 308753-B68998404 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $0.3586 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $90.95 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $34.32 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 77.00% Worth It (20 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Laxative Enteric Coated (Bisacodyl 5mg) Patient Community, Cohort Filters & Dosage Logs
Cross-verified Laxative Enteric Coated (Bisacodyl 5mg) (stimulant laxative) monograph synthesizing RxNorm 308753-B68998404, openFDA FAERS signals, and $34.32–$90.95 cash benchmarks.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Laxative Enteric Coated (Bisacodyl 5mg) community threads and patient logs by age, biological sex, dosage, and treatment duration.